Hammond C B, Wiebe R H, Haney A F, Yancy S G
Am J Obstet Gynecol. 1979 Dec 1;135(7):924-39. doi: 10.1016/0002-9378(79)90819-6.
Thirteen women with infertility thought due to anovulation were treated with LRH. Etiologic diagnoses of amenorrhea included hypothalamic or "idiopathic" and PCOD. All patients had normal gonadotropins and otherwise normal endocrinologic and infertility evaluations; none had ovulated with clomiphene. Patients were studied for six 35 day cycles, single blind, and received LRH or placebo by subcutaneous injections for 28 days/cycle (LRH dosage 1.0 mg 2 or 3 times each day). Frequent assessments of physical status, cervical mucus, vaginal cytology, and serum LH, FSH, estrogen, and progesterone were performed. Ovulation was documented by basal temperature, serum progesterone and, on occasion, endometrial biopsy. Follow-up was continued for 6 months after therapy. Of the 13 patients treated, eight have ovulated and five have conceived. There were no complications of therapy.
13名因无排卵被认为患有不孕症的女性接受了促黄体释放激素(LRH)治疗。闭经的病因诊断包括下丘脑性或“特发性”以及多囊卵巢综合征(PCOD)。所有患者促性腺激素水平正常,其他内分泌及不孕症评估也均正常;所有人使用克罗米芬均未排卵。对患者进行了6个周期、每个周期35天的单盲研究,每个周期皮下注射LRH或安慰剂28天(LRH剂量为每日1.0毫克,2次或3次)。对身体状况、宫颈黏液、阴道细胞学以及血清促黄体生成素(LH)、促卵泡生成素(FSH)、雌激素和孕激素进行了频繁评估。通过基础体温、血清孕酮以及偶尔进行的子宫内膜活检记录排卵情况。治疗后持续随访6个月。在接受治疗的13名患者中,8人排卵,5人怀孕。治疗无并发症发生。